Who are Tetracaine drop's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Lidocaine solution ("A"), Lidocaine gel 2%, Control (bupivacaine), Lidocaine (drug), Dexamethasone+ Bupivacaine, Lidocaine/tetracaine patch.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/tetracaine-drop.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Tetracaine drop — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tetracaine drop (Tetracaine drop) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic (ester). Area: Ophthalmology.

marketed Local anesthetic (ester) Voltage-gated sodium channels Ophthalmology Small molecule Live · refreshed every 30 min

Target snapshot

Tetracaine drop (Tetracaine drop) — University of Miami. Tetracaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Tetracaine drop TARGET	Tetracaine drop	University of Miami	marketed	Local anesthetic (ester)	Voltage-gated sodium channels
Lidocaine solution ("A")	Lidocaine solution ("A")	Hospital Universitari de Bellvitge	marketed	Local anesthetic	Voltage-gated sodium channels
Lidocaine gel 2%	Lidocaine gel 2%	Atlantic Health System	marketed	Local anesthetic	Voltage-gated sodium channels
Control (bupivacaine)	Control (bupivacaine)	Kasr El Aini Hospital	marketed	Local anesthetic (amide)	Voltage-gated sodium channels
Lidocaine (drug)	Lidocaine (drug)	Daniel A Tonetti, MD	marketed	Local anesthetic	Voltage-gated sodium channels
Dexamethasone+ Bupivacaine	Dexamethasone+ Bupivacaine	Ain Shams University	marketed	Corticosteroid + Local anesthetic combination	Glucocorticoid receptor (dexamethasone); Voltage-gated sodium channels (bupivacaine)
Lidocaine/tetracaine patch	Lidocaine/tetracaine patch	East Carolina University	marketed	Local anesthetic combination	Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic (ester) class)

Sintetica SA · 4 drugs in this class
Centre Hospitalier Universitaire Saint Pierre · 1 drug in this class
Nova Scotia Health Authority · 1 drug in this class
American Genomics, LLC · 1 drug in this class
University of Miami · 1 drug in this class
Wenzhou Medical University · 1 drug in this class
Oregon Health and Science University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Tetracaine drop — Competitive Intelligence Brief. https://druglandscape.com/ci/tetracaine-drop. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab